1. V. Fusco, A. Baraldi, A. Fasciolo, A. Pertino, and R. Gaino. (2014). Decreased occurrence of ONJ after preventive measures: the Alessandria experience on a 471 bisphosphonate patient population. Ann Stomatol (Roma). 2014 Apr-Jun; 5(2 Suppl): 45–46..
2. M. Vincenti, A. Fasciolo, P. Pepe, A. Pertino, and V. Fusco. (2014). ONJ (osteonecrosis of jaw) in breast cancer patients: effect of preventive measures in a mono institutional experience. Ann Stomatol (Roma). 2014 Apr-Jun; 5(2 Suppl): 14..
3. P. Guglielmini, V. Fusco, A. Fasciolo, P. Pepe, and A. Pertino. (2014). Osteonecrosis of jaw (ONJ) in prostate cancer patients: report of a monoinstitutional experience. Ann Stomatol (Roma). 2014 Apr-Jun; 5(2 Suppl): 43..
4. G. Catania, F. Monaco,A. Baraldi, A. Fasciolo, and A. Pertino. (2014). ONJ (osteonecrosis of jaw) in myeloma patients: a monoistitutional experience of 117 patients treated with bisphosphonates. Ann Stomatol (Roma). 2014 Apr-Jun; 5(2 Suppl): 7–8..
5. A. Pertino, R. Gaino, D. Tartara, and M. G. Candeo. (2014). Role of nurses in a multidisciplinary team for prevention, diagnosis, treatment and follow-up of osteonecrosis of jaw (ONJ). Ann Stomatol (Roma). 2014 Apr-Jun; 5(2 Suppl): 31–32..